Meeting
2021 ASCO Annual Meeting
Genomic profiling of KRAS wide-type pancreatic ductal adenocarcinomas identifies targetable genetic alterations.
Authors
Deng Wei
Department of General Surgery, Beijing Friendship Hospital;Capital Medical University;Beijing Key Laboratory of Cancer Invasion and Metastasis Research & National Clinical Research Center for Digestive Diseases, Beijing, China
Deng Wei , Xiaomo Li , Xinsheng Zhang , Tonghui Ma , Rong Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4121)
DOI
10.1200/JCO.2021.39.15_suppl.4121
Abstract #
4121
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling (CGP) in KRAS wild-type (WT) pancreatic ductal adenocarcinoma (PDAC).
First Author: Ben George
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2018 Gastrointestinal Cancers Symposium
Molecular and clinical characterization of BRAF mutations in pancreatic ductal adenocarcinomas (PDACs).
First Author: Michelle Guan
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of pancreatic cancer (PC): KRAS wild type vs. KRAS mutant tumors and primary tumors vs. distant metastases.
First Author: Mohamed E. Salem